GA in Practice

In this Feature

GA in the Presence of Dense Cataract, Followed by CNV Development

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Delayed Complement Inhibition Therapy per Patient Request

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

GA Patient Who Becomes Monocular Over Time Due to the Wet AMD

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Complement Inhibition Therapy in a Monocular Patient With a New CNV

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Multimodal Imaging for Biomarker Detection in GA Patients

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Why Retina Specialists Are Growing More Comfortable With Early Treatment

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Talking to Patients About Treatment Risks

Geeta Lalwani, MD; Murtaza Adam, MD; and Carl Danzig, MD

Interactive Supplements

Barriers to Care, Patient Education, and Treatment Decisions in Geographic Atrophy

Listen on Eyetube

Evolving Practice Patterns and Dosing Strategies in Geographic Atrophy

Listen on Eyetube

Biomarkers, Imaging, and Early Treatment Decisions in Geographic Atrophy

Listen on Eyetube

About This Editorial Feature

GA in Practice explores practical strategies for managing geographic atrophy (GA) across the patient journey. Moderator Geeta Lalwani, MD, and panelists Murtaza Adam, MD, and Carl Danzig, MD, discuss how imaging biomarkers, evolving real-world experience with complement inhibition, and individualized dosing strategies inform early treatment decisions. Through real-world cases, they examine how lesion characteristics, lifestyle, and risk counseling influence management while addressing common barriers to care. The series also highlights the growing role of patient education and emerging technologies in supporting personalized GA care

Editorial Feature:

In this Feature

Interactive Supplements